University of Crete (UOC)
Development of implant treatments with neuroprotective and neurogenic activities for central nervous system injuries
Abstract
dc:descriptionCentral Nervous System (CNS) injuries, such as spinal cord or optic nerve injuries (SCI, ONI), affect thousands of individuals worldwide. Still no cure can handle the complex multifactorial nature of CNS injury. Along this direction, the present thesis evaluates novel combinatorial treatments for CNS injuries that contain three components: 1) Porous collagen-based scaffolds (PCS), biomaterials that provide structural support, inflammation regulation, a substrate for cellular migration and axonal elongation as well as a delivery system of therapeutic molecules or cells, 2) Neural Stem Cells (NSC), multipotent cells that can replace neuronal cells lost during CNS injuries, 3) Microneurotrophins (MNT), small-molecule mimetics of endogenous neurotrophins, that have demonstrated significant therapeutic effects on various animal models of human neurological diseases, but have not been evaluated in rodent models of CNS injuries yet.The first part of this thesis focuses on evaluating the effects of BNN27, the seminal MNT, on the mouse optic nerve crush (ONC) model. Results provide the first evidence on the effects of BNN27 on animal models of ONI. In particular, BNN27 administration significantly increased RGC survival and decreased microglia-mediated inflammation at 2 weeks post injury (wpi). BNN27 was delivered via eye drops or via a PCS graft. Interestingly, this study presents the first administration of MNT via a biomaterial graft and it highlights a more consistent and efficient neuroprotective effect provided by a targeted delivery at the injury site. The second part of this thesis focuses on evaluating the effects of combinatorial treatments on the dorsal column crush mouse SCI model. The first SCI study evaluated mouse embryonic NSC-seeded PCS grafts in this SCI model. The second SCI study combined NSC-seeded PCS grafts with systemic administration of BNN27. This thesis highlights PCS grafts as a promising delivery method of NSCs in SCI lesions, contrary to the widely used method of delivering NSCs in suspension via injection. NSC-seeded PCS grafts decreased glial scar and enhanced crucial events following SCI, such as neuron density, synaptogenesis, axonal elongation and angiogenesis at 12 wpi. Notably, NSC-seeded PCS grafts also led to statistically significant locomotion recovery starting at 9-10 wpi. This thesis also demonstrates the first evidence on the effects of BNN27 on animal models of SCI. Systemic administration of BNN27 decreased astrogliosis and neuronal loss following SCI. In addition, when BNN27 administration was combined with the implantation of NSC-seeded PCS grafts, BNN27 significantly increased the density of implanted NSC-derived cells, possibly addressing a major challenge of emerging NSC-based cell therapies.In conclusion, this thesis presents novel combinatorial treatments that could cope with the complexity of CNS injuries and could hopefully be new tools in regenerative medicine leading to the design of more effective therapies with clinical application.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Georgelou, Konstantina
- Γεωργέλου, Κωνσταντίνα
Subjects
dc:subject × 16- Κεντρικό νευρικό σύστημα, τραύμα
- Νευροτροφίνες
- Νευρικά βλατικά κύτταρα
- Βιοϋλικά
- Αναγεννητική ιατρική
- Central nervous system injuries
- Neurotrophins
- Neural stem cells
- Biomaterials
- Regenerative medicine
- Άλλες Ιατρικές Επιστήμες
- Ιατρική και Επιστήμες Υγείας
- Ιατρική, άλλοι τομείς
- Other Medical Sciences
- Medical and Health Sciences
- Medicine, miscellaneous
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53865